Britain’s National Health Service to administer meningitis B infection

Published On 2015-09-04 04:52 GMT   |   Update On 2015-09-04 04:52 GMT
Advertisement
Britain's National Health Service (NHS) is reportedly the world's first public health body to agree to administer a new vaccine against the potentially deadly meningitis B infection.

The meningococcal disease in children can prove fatal for infants in one of ten cases; however, it can be properly controlled by vaccine. Under this new development, all newborn babies in England and Scotland are to be offered a vaccine to combat meningitis B from September, the government has announced, as reported by BBCnews.com.
Advertisement

The Men B vaccine will be given to babies at two months, four months and 12 months old.

Meningitis is an infection of the meninges - the membrane that surrounds the brain and spinal cord. Meningococcal bacteria are common and carried harmlessly in the nose or throat by about one in 10 people. Anyone can get meningitis but babies and young children are most vulnerable. Symptoms include a high fever with cold hands and feet, agitation, confusion, vomiting and headaches

In this case, the vaccine developed by the NHS, has the potential to prevent over 4000 cases under five, as said by some experts.

"We, along with our supporters, have campaigned for over two years to see the ground-breaking vaccine free on the NHS," Steve Dayman, founder of the charity Meningitis Now said.

 
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News